WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 555

Legislative bill overview

HB 555 proposed to revise Montana's laws governing medication abortion (chemical abortion). The bill died in the legislative process during the 2025 session after being tabled in the House Judiciary Committee and missing the deadline for general bill transmittal.

Why is this important

Medication abortion represents a significant portion of abortions in the U.S., and state regulations around these drugs (primarily mifepristone and misoprostol) have become increasingly contested. Any changes to Montana's chemical abortion laws would affect healthcare access, regulatory requirements, and medical practice standards in the state.

Potential points of contention

  • Scope of restrictions: The bill's specific provisions remain unclear from available records, but potential regulations could include waiting periods, dosage controls, telehealth limitations, or gestational age cutoffs
  • Medical practice standards: Changes to chemical abortion protocols may conflict with recommendations from medical organizations like ACOG or create barriers for healthcare providers
  • Access and equity: Regulatory changes could disproportionately affect rural Montanans and those with limited healthcare resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.